ricolinostat: Clinical Trials

4 trials of ricolinostat, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated. 4 Phase 2, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Terminated 2
Phase 13Terminated 2, Completed 1

Follow ricolinostat: new trials by email Literature Review of ricolinostat trials Research Report on ricolinostat

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy
ricolinostat, Placebo - Painful Diabetic Peripheral Neuropathy
Phase 2CompletedRegenacy Pharmaceuticals LLC2822020-12-072023-09-21
ACY-1215 for Relapsed/Refractory Lymphoid Malignancies
ACY-1215 - Lymphoma, Lymphoid Malignancies
Phase 1 / Phase 2TerminatedJennifer Amengual232014-04-022024-08-06
ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Low-dose Dex in Relapsed-and-Refractory Multiple Myeloma
ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone - Multiple Myeloma
Phase 1 / Phase 2TerminatedCelgene1032014-03-012025-03-04
Study of ACY-1215 Alone and in Combination With Bortezomib and Dexamethasone in Multiple Myeloma
ACY-1215 - Multiple Myeloma
Phase 1 / Phase 2CompletedCelgene1202011-07-012017-04-06

Conditions studied

Multiple Myeloma (2)  ·  Blood Protein Disorders (1)  ·  Hematologic Diseases (1)  ·  Hematologic Neoplasms (1)  ·  Lymphoma (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Plasma Cell (1)  ·  Neuralgia (1)

Sponsors

Celgene (2)  ·  Jennifer Amengual (1)  ·  Regenacy Pharmaceuticals LLC (1)

Countries

United States (4)

Top investigators

Jennifer E Amengual, MD (1)  ·  Sagar Lonial, MD (1)